Adults 55 to 80, any sex, with Smoking Cessation. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Report's Impact Making a Quit Attempt Measured Via Follow-up Phone CallPrimary· 3 weeks after intervention
This outcome will be measured by the participants' motivation to make a quit attempt and abstain from smoking. The question asked was: How ready are you to quit smoking?
Answer options include:
1. Not at all ready
2. Slightly ready
3. Moderately ready
4. Very ready
Group
Value
95% CI
Usual Care
2.73
± 0.84
Usual Care + Imbio Smoking Cessation Report
3.15
± 0.90
Usual Care + Counseling
2.92
± 0.87
Usual Care + Imbio Smoking Cessation Report + Counseling
2.97
± 0.92
Report's Impact Making a Quit Attempt Measured Via Follow-up Phone CallPrimary· 3 months after intervention
This outcome will be measured by the participants' motivation to make a quit attempt and abstain from smoking. The question asked was: How ready are you to quit smoking?
Answer options include:
1. Not at all ready
2. Slightly ready
3. Moderately ready
4. Very ready
Group
Value
95% CI
Usual Care
2.75
± 0.92
Usual Care + Imbio Smoking Cessation Report
3.08
± 0.92
Usual Care + Counseling
2.61
± 0.98
Usual Care + Imbio Smoking Cessation Report + Counseling
3.07
± 0.90
Report's Impact Making a Quit Attempt Measured Via Follow-up Phone CallPrimary· 6 months after intervention
This outcome will be measured by the participants' motivation to make a quit attempt and abstain from smoking. The question asked was: How ready are you to quit smoking?
Answer options include:
1. Not at all ready
2. Slightly ready
3. Moderately ready
4. Very ready
Group
Value
95% CI
Usual Care
2.85
± 0.88
Usual Care + Imbio Smoking Cessation Report
3.00
± 0.93
Usual Care + Counseling
2.80
± 0.93
Usual Care + Imbio Smoking Cessation Report + Counseling
3.07
± 0.96
Sponsor's own description
Imbio is developing a Smoking Cessation Report (Report) that includes data analysis from a CT lung cancer screening exam. This randomized controlled (RCT) trial will clinically validate the Report's effectiveness at motivating smokers to call a Quitline.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Imbio
Last refreshed: 5 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03087617.